Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial

AIMS: After percutaneous coronary intervention (PCI) in patients with atrial fibrillation, safety and efficacy with dabigatran dual therapy were evaluated in pre-specified subgroups of patients undergoing PCI due to acute coronary syndrome (ACS) or elective PCI, and those receiving ticagrelor or clo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Heart J
Main Authors: Oldgren, Jonas, Steg, Philippe Gabriel, Hohnloser, Stefan H, Lip, Gregory Y H, Kimura, Takeshi, Nordaby, Matias, Brueckmann, Martina, Kleine, Eva, ten Berg, Jurrien M, Bhatt, Deepak L, Cannon, Christopher P
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6514838/
https://ncbi.nlm.nih.gov/pubmed/30793734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehz059
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados